Loading…
NeuroOne Medical Technologies Corporation is projected to rise to $3.46 by 2027, a +26% move from its current price of $2.75. NMTC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.66 | $2.75 | $2.84 | +0.03% |
| Jul 14 | $2.62 | $2.75 | $2.88 | +0.06% |
| Jul 15 | $2.60 | $2.75 | $2.92 | +0.09% |
| Jul 16 | $2.58 | $2.75 | $2.94 | +0.12% |
| Jul 17 | $2.56 | $2.75 | $2.97 | +0.14% |
| Jul 18 | $2.54 | $2.75 | $2.99 | +0.17% |
| Jul 19 | $2.52 | $2.76 | $3.01 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.52 | $2.76 | $3.01 | +0.20% |
| Week 2 | $2.44 | $2.76 | $3.13 | +0.40% |
| Week 3 | $2.37 | $2.77 | $3.22 | +0.61% |
| Week 4 | $2.32 | $2.77 | $3.31 | +0.81% |
| Week 5 | $2.28 | $2.78 | $3.38 | +1.01% |
| Week 6 | $2.24 | $2.78 | $3.45 | +1.22% |
| Week 7 | $2.21 | $2.79 | $3.52 | +1.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NeuroOne Medical Technologies Corporation is a medical technology company that provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company is based in Eden Prairie, Minnesota.
It has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies.
NMTC is the NeuroOne Medical Technologies Corporation, listed in the healthcare sector. It is currently priced at $2.75 per share with a market cap of $23.93M and a market rank of 4854. The stock trades within a near-term range and shows a neutral posture in the current technical backdrop.
The broader price outlook is supported by a multi-year forecast that projects gradual upside across several years, with bullish trajectories from 2027 onward.
A major floor 21.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 35.3% above — a clean break opens room to run.
A major ceiling 85.8% above — clearing it would confirm fresh momentum.
Key NMTC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NMTC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.95 | Sell | $2.92 | Sell |
| MA 10 | $3.04 | Sell | $3.01 | Sell |
| MA 20 | $3.16 | Sell | $3.17 | Sell |
| MA 50 | $3.69 | Sell | $3.58 | Sell |
| MA 100 | $4.12 | Sell | $3.95 | Sell |
| MA 200 | $4.46 | Sell | $4.28 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.74 | Neutral |
| Stoch RSI (14) | 48.87 | Neutral |
| CCI (20) | -124.00 | Sell |
| Williams %R (14) | -78.33 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -14.03 | Sell |
| Bollinger %B (20,2) | 0.09 | Neutral |
| Stochastic %K (14) | 21.67 | Neutral |
| TRIX (15) | -0.86 | Sell |
| Awesome (5,34) | -0.39 | Sell |
| Ultimate (7,14,28) | 35.86 | Neutral |
| Momentum (10) | -0.32 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 2.84 | Sell |
| ADX (14) | 28.47 | Sell |
| ATR (14) | 0.10 | Info |
The 30-day technical picture shows a NEUTRAL sentiment with an RSI of 30. The stock’s short-term moving average is above the price at the SMA50 of $3.73 and SMA200 of $4.47, indicating mixed momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.75 | $2.75 | $3.75 | 0% | Neutral | |
| $2.70 | $3.46 | $4.73 | +26% | Bullish | |
| $3.32 | $4.40 | $6.29 | +60% | Bullish | |
| $3.15 | $4.31 | $6.37 | +57% | Bullish | |
| $2.91 | $4.08 | $6.20 | +48% | Bullish | |
| $3.16 | $4.54 | $7.08 | +65% | Bullish | |
| $3.01 | $4.42 | $7.04 | +61% | Bullish | |
| $3.48 | $5.23 | $8.49 | +90% | Bullish | |
| $4.22 | $6.45 | $10.68 | +135% | Bullish | |
| $4.05 | $6.32 | $10.64 | +130% | Bullish | |
| $5.42 | $9.22 | $16.66 | +235% | Bullish | |
| $7.14 | $14.22 | $28.44 | +417% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.75 | $2.75 | $3.44 | +0.00% |
| August 2026 | $2.42 | $2.88 | $3.52 | +4.57% |
| September 2026 | $2.36 | $2.82 | $3.50 | -1.83% |
| October 2026 | $2.43 | $2.93 | $3.68 | +3.81% |
| November 2026 | $2.48 | $3.01 | $3.81 | +2.78% |
| December 2026 | $2.41 | $2.94 | $3.75 | -2.48% |
Click any year to see its month-by-month NMTC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NMTC price prediction for 2026 points to an average of $2.75 (low $2.75, high $3.75) — a potential gain of 0% on today's $2.75. A consolidation phase looks the most probable path here.
In 2027, NMTC is projected to trade between $2.70 and $4.73, averaging $3.46 — a potential gain of +26% from today's $2.75. That is up +26% on the projected 2026 average. Momentum favours further upside here.
NeuroOne Medical Technologies Corporation's 2028 outlook centres on $4.40, within a $3.32 to $6.29 range. That is up +27% on the projected 2027 average. That marks a +60% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, NMTC could reach as high as $6.37, with a base case around $4.31 and support toward $3.15 — roughly +57% from $2.75. Momentum favours further upside here.
Expect NMTC to range from $2.91 to $6.20 through 2030. The $4.08 average target implies a +48% move from current prices. That is -5% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The NMTC price prediction for 2031 points to an average of $4.54 (low $3.16, high $7.08) — a potential gain of +65% on today's $2.75. Momentum favours further upside here.
In 2032, NMTC is projected to trade between $3.01 and $7.04, averaging $4.42 — a potential gain of +61% from today's $2.75. That is -3% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
NeuroOne Medical Technologies Corporation's 2033 outlook centres on $5.23, within a $3.48 to $8.49 range. That is up +18% on the projected 2032 average. That marks a +90% change versus current levels. Momentum favours further upside here.
By 2034, NMTC could reach as high as $10.68, with a base case around $6.45 and support toward $4.22 — roughly +135% from $2.75. Buyers look set to stay in control over this stretch.
Expect NMTC to range from $4.05 to $10.64 through 2035. The $6.32 average target implies a +130% move from current prices. That is -2% versus the projected 2034 average. Momentum favours further upside here.
The NMTC price prediction for 2040 points to an average of $9.22 (low $5.42, high $16.66) — a potential gain of +235% on today's $2.75. Buyers look set to stay in control over this stretch.
In 2050, NMTC is projected to trade between $7.14 and $28.44, averaging $14.22 — a potential gain of +417% from today's $2.75. That is up +54% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in NMTC today (≈ 363.636364 NMTC) could be worth
$5,170.01
+$4,170.01 (+417%) by 2050 · US Dollar
Based on the average projected NMTC price of $14.22 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NMTCwould be worth at today's price.
$1,000 invested in NMTC on Jul 10, 2025 (≈ 222.222222 NMTC) would be worth
$611.11
-$388.89 (-38.9%) today · 0.61× · US Dollar
Based on a NMTC entry price of $4.5 vs. today's $2.75.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3 | $916.67 | -8.3% |
| 1 month ago | $3.32 | $828.31 | -17.2% |
| 3 months ago | $4.39 | $626.14 | -37.4% |
| 6 months ago | $5.36 | $513.25 | -48.7% |
| 1 year ago | $4.5 | $611.11 | -38.9% |
| All time (5.0y) ago | $35.4 | $77.68 | -92.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NMTC forecast.
Our base-case forecast reaches $5.50 around 2034.
Implied market cap at $5.50: $47.87M
The multi-year forecast points to a bullish trajectory beyond 2026. In 2026 the avg is $2.75 with a 0% ROI and NEUTRAL sentiment. In 2027 the avg is $3.42 with a 24.5% ROI and a BULLISH sentiment, followed by 2028 with an avg of $4.34 and 57.9% ROI, and 2029 with an avg of $4.24 and 54.3% ROI.
By 2030 the avg is $4.02 with a 46% ROI and BULLISH sentiment, then 2031 avg $4.45 (61.9% ROI), 2032 avg $4.31 (56.8% ROI), 2033 avg $5.06 (84.2% ROI), 2034 avg $6.25 (127.2% ROI), and 2035 avg $6.13 (122.8% ROI). The forecast continues to 2040 with an avg of $8.84 and 221.3% ROI, and finally 2050 with an avg of $13.61 and 394.9% ROI, all marked BULLISH. These are estimates, not guarantees, and reflect potential upside and risk over a long horizon.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $4.02 with a max of $6.09 and a min of $2.87, and a 46% ROI, with a BULLISH sentiment.
The outlook shows multiple years flagged as BULLISH with rising avg prices (e.g., 2027 avg $3.42, 2028 avg $4.34, 2030 avg $4.02, 2040 avg $8.84, 2050 avg $13.61) and positive ROI, but the 2026 year is neutral and these are estimates, not guarantees.
Yes. The 2035 forecast lists a max of $10.28, while the avg is $6.13 and the min is $3.94.
Current price is $2.75. The 30-day range is $2.21 to $3.42.
Market cap is $23.93M and the rank is 4854.
NeuroOne Medical Technologies Corporation Community Discussion
0Share your NeuroOne Medical Technologies Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.